Cyclosporine Dosage Guide: Research Protocols, Timing & Reconstitution

Standard Dosage Range

Research dosing range: Highly variable; individualized based on indication, formulation, and blood levels.

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Organ Transplant Rejection Prophylaxis (Kidney, Liver, Heart)

Initially 10-15 mg/kg/day (oral), or 2-6 mg/kg/day (IV) divided into two doses; adjust to maintain target trough levels.2× daily

Duration

Long-term; often indefinite post-transplant

Dose adjustments based on blood level monitoring are crucial. Target trough levels vary depending on the organ and time post-transplant. Lower doses are generally possible with concomitant immunosuppressants.

Rheumatoid Arthritis

2.5-5 mg/kg/day (oral), divided into two doses2× daily

Duration

Up to 6 months; may be longer under close monitoring

Monitor blood pressure and renal function regularly. Discontinue if no improvement after 6 months or if unacceptable toxicity occurs.

Psoriasis

2.5-5 mg/kg/day (oral), divided into two doses2× daily

Duration

Limited to 1 year due to potential for nephrotoxicity

Reserve for severe, recalcitrant psoriasis unresponsive to other therapies. Monitor blood pressure and renal function regularly.

Dry Eye Disease (Restasis)

One drop in each eye, twice daily2× daily

Duration

Long-term; as needed for symptom relief

Restasis is a topical formulation designed for ophthalmic use only. It may take several weeks to months to achieve maximal benefit.

Timing & Frequency

Administer consistently with regard to meals to ensure consistent absorption, especially with non-modified formulations. Timing may be less critical with modified formulations (e.g., Neoral, Gengraf).

Cycle Guidance

Cyclosporine is not typically cycled due to its immunosuppressive effects and the need for continuous therapy in many indications (e.g., organ transplant). Discontinuation should only occur under the guidance of a healthcare professional.

Reconstitution Reference

Quick reference for reconstituting Cyclosporine. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial Size	N/A (typically available as capsules, oral solution, or IV solution)
BAC Water Volume	N/A
Concentration & Draw	Concentration varies depending on the formulation. Refer to product labeling for specific information.
Storage	Store according to manufacturer's instructions. Protect from light and heat.
Stability	Refer to product labeling for stability information.

Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the standard cyclosporine dosage for kidney transplant?

The initial oral dosage is typically 10-15 mg/kg/day, divided into two doses. This is adjusted based on trough blood levels to maintain therapeutic efficacy and minimize toxicity. Trough levels are monitored closely post-transplant, and the target range changes over time.

How often should I take cyclosporine?

Cyclosporine is typically taken twice daily, but the specific frequency and timing depend on the formulation and your doctor's instructions. Adherence to the prescribed schedule is crucial for maintaining consistent blood levels.

What are the common side effects of cyclosporine?

Common side effects include nephrotoxicity (kidney damage), hypertension (high blood pressure), tremor, hirsutism (excess hair growth), gingival hyperplasia (gum overgrowth), and gastrointestinal disturbances. Regular monitoring is important to detect and manage potential side effects.